Mô tả

Emerging phytocannabinoid formulations for epilepsy include transdermal, intranasal, and sublingual delivery systems. Alternative routes of administration may improve bioavailability and reduce gastrointestinal side effects.

Figure 30

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 30: Emerging phytocannabinoid formulations for epilepsy include transdermal, intranasal, and sublingual delivery systems. Alternative routes of administration may improve bioavailability and reduce gastrointestinal side effects.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Emerging phytocannabinoid formulations for epilepsy include transdermal, intranasal, and sublingual delivery systems. Alternative routes of administration may improve bioavailability and reduce gastrointestinal side effects." />
  <figcaption>Figure 30. Emerging phytocannabinoid formulations for epilepsy include transdermal, intranasal, and sublingual delivery systems. Alternative routes of administration may improve bioavailability and reduce gastrointestinal side effects.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Bằng chứng liên quan

CBD cho Mất Ngủ

Xếp hạng A · 103 nghiên cứu